AndrewM.BlumenfeldMD

Neurology • Carlsbad, CA

Headache

Director of the Headache Center of Southern California

Join to view full profile

Dr. Blumenfeld is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Blumenfeld's full profile

Already have an account?

Office
6010 Hidden Valley Rd Ste 200
Suite 2
Carlsbad, CA 92011
Phone+1 760-631-3000

Fax+1 760-631-3016

Education & Training

UMass Chan Medical SchoolResidency, Neurology, 1986 - 1990
University of the WitwatersrandClass of 1981

Certifications & Licensure

CA State Medical License 1989 - 2025
American Board of Psychiatry and Neurology Neurology

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification NextGen Ambulatory EHR, NextGen Healthcare, 2012-2013

Publications & Presentations

PubMed

54 citations
The Importance of Carotid Artery Plaque Disruption and Hemorrhage
Marc Fisher, Andrew M. Blumenfeld, Thomas W. Smith
Archives of Neurology. 1987-10-01
4 citations
Real-world persistence and costs among patients with chronic migraine treated with onabotulinumtoxinA or calcitonin gene-related peptide monoclonal antibodies.
Todd J Schwedt, Jae Lee, Kerry Knievel, Jennifer McVige, Weiying Wang
Journal of Managed Care & Specialty Pharmacy. 2023-10-01
103 citations
Mechanism of Action of OnabotulinumtoxinA in Chronic Migraine: A Narrative Review.
Rami Burstein, Andrew M. Blumenfeld, Stephen D. Silberstein, Aubrey Manack Adams, Mitchell F. Brin
Headache. 2020-07-01

Lectures

InjectionED: Advanced Injection Training for Pain Disorders of the Head, Neck & Face
Cvent Online Event Registration Software, San Diego, California - 12/1/2012
Headaches: Easing the Pain
Scripps Conference Services & CME /Scripps Translational Science Institute (STSI), La Jolla, Califor - 2/18/2012

Press Mentions

Treating Chronic Migraine: One Woman’s Path to Managing the DiseaseMarch 9th, 2023
Theranica's Nerivio® Cleared by FDA for Preventive Treatment of MigraineFebruary 28th, 2023
Teva Announces New Analysis of Consistency in Migraine Days over the Course of a Dosing Regimen for AJOVY® (Fremanezumab-Vfrm) Injection Published in HeadacheOctober 7th, 2020
Join now to see all